Literature DB >> 12064478

Cdk5 phosphorylates p53 and regulates its activity.

Jianwen Zhang1, Pavan K Krishnamurthy, Gail V W Johnson.   

Abstract

Cyclin dependent kinase 5 (Cdk5) is a proline-direct protein kinase that is most active in the CNS, and has been implicated as a contributing factor in certain neurodegenerative diseases. Further, there is evidence to suggest that Cdk5 may facilitate the progression of apoptosis. However, the mechanisms involved have not been elucidated. The tumor suppressor protein p53, a transcription factor that is regulated by phosphorylation, increases the expression of genes that control growth arrest or cell death. To understand how Cdk5 could facilitate apoptosis, the effects of Cdk5 on p53 activity were examined. In the present study it is shown that in apoptotic PC12 cells the levels of p53 and Cdk5 increase concomitantly. Further, Cdk5/p25 effectively phosphorylates recombinant p53 in vitro. Transient transfection of Cdk5/p25 into cells results in an increase in p53 levels, as well as the expression of the p53-responsive genes p21 and Bax. Furthermore, evidence is provided that increased Cdk5 activity increases p53 transcriptional activity significantly, suggesting that p53 is modulated in situ by Cdk5. This is the first demonstration that p53 is a substrate of Cdk5, and that Cdk5 can modulate p53 levels and activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064478     DOI: 10.1046/j.1471-4159.2002.00824.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  32 in total

Review 1.  Gene-set analysis and reduction.

Authors:  Irina Dinu; John D Potter; Thomas Mueller; Qi Liu; Adeniyi J Adewale; Gian S Jhangri; Gunilla Einecke; Konrad S Famulski; Philip Halloran; Yutaka Yasui
Journal:  Brief Bioinform       Date:  2008-10-04       Impact factor: 11.622

2.  Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

Authors:  James I Macdonald; Frederick A Dick
Journal:  Genes Cancer       Date:  2012-11

3.  Tumor suppressor p53 status does not determine the differentiation-associated G₁ cell cycle arrest induced in leukemia cells by 1,25-dihydroxyvitamin D₃ and antioxidants.

Authors:  Thelma Thompson; Michael Danilenko; Lyubomir Vassilev; George P Studzinski
Journal:  Cancer Biol Ther       Date:  2010-08-13       Impact factor: 4.742

Review 4.  Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection.

Authors:  M Slevin; J Krupinski; P Kumar; J Gaffney; S Kumar
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

5.  Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Jan-Gowth Chang; Kun-Tu Yeh; Rong-Ming Chen; Jeffrey J P Tsai; Rouh-Mei Hu
Journal:  Med Oncol       Date:  2010-10-09       Impact factor: 3.064

Review 6.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

7.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease.

Authors:  Patrice D Smith; Stephen J Crocker; Vernice Jackson-Lewis; Kelly L Jordan-Sciutto; Shawn Hayley; Matthew P Mount; Michael J O'Hare; Steven Callaghan; Ruth S Slack; Serge Przedborski; Hymie Anisman; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

8.  Phosphorylation of PPP(S/T)P motif of the free LRP6 intracellular domain is not required to activate the Wnt/beta-catenin pathway and attenuate GSK3beta activity.

Authors:  Brandon Beagle; Kaihong Mi; Gail V W Johnson
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

9.  Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity.

Authors:  Amy K Y Fu; Wing-Yu Fu; Alberto K Y Ng; Winnie W Y Chien; Yu-Pong Ng; Jerry H Wang; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

10.  SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis.

Authors:  Dohoon Kim; Minh Dang Nguyen; Matthew M Dobbin; Andre Fischer; Farahnaz Sananbenesi; Joseph T Rodgers; Ivana Delalle; Joseph A Baur; Guangchao Sui; Sean M Armour; Pere Puigserver; David A Sinclair; Li-Huei Tsai
Journal:  EMBO J       Date:  2007-06-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.